Coccidioidomycosis: Epidemiology

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 185-197

  Brown, Jennifer ^a   Benedict, Kaitlin ^b   Park, Benjamin J ^b   Thompson III, George R ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coccidioides; Coccidioidomycosis; Epidemiology; Geography; Incidence; Risk factors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; CENTRAL AMERICA; CLIMATE CHANGE; COCCIDIOIDES; COCCIDIOIDES IMMITIS; COCCIDIOIDES POSADASII; COCCIDIOIDOMYCOSIS; DIABETES MELLITUS; DISEASE CARRIER; DISEASE SEVERITY; ECOLOGY; ENDEMIC DISEASE; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEVER; GENDER; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; LIFE CYCLE; MEXICO; NONHUMAN; PREGNANT WOMAN; PRISONER; PUBLIC HEALTH; REVIEW; UNITED STATES;

EID: 84879496264     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S34434     Document Type: Review

References (127)

1. Thompson GR 3rd. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med. 2011;32(6):754-763.
2. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005;41(9):1217-1223.
3. Barker BM, Jewell KA, Kroken S, Orbach MJ. The population biology of coccidioides: epidemiologic implications for disease outbreaks. Ann N Y Acad Sci. 2007;1111:147-163.
4. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Medi Mycol. 2011;49(8):785-798.
5. Laniado-Laborin R. Expanding understanding of epidemiology of coccidioidomycosis in the Western hemisphere. Ann N Y Acad Sci. 2007;1111:19-34.
6. Hirschmann JV. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis. 2007;44(9):1202-1207.
7. Rixford EGT. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;10:209-268.
8. Ophuls W. Further observations on a pathogenic mould formerly described as a protozoan (Coccidioides immitis, Coccioides pyogenes). J Exp Med. 1905;6(4-6):443-485.
9. Dickson EC GM. Coccidioides Infection (Coccidioidomycosis): ii. The primary type of infection. Arch Intern Med. 1938;62(5):853-871.
10. Smith CE. Epidemiology of Acute Coccidioidomycosis with Erythema Nodosum ("San Joaquin" or "Valley Fever"). Am J Public Health Nations Health. 1940;30(6):600-611.
11. Davis BL SR, Smith CE. An epidemic of coccidioidal infection (coccidioidomycosis). JAMA. 1942;118:1182-1186.
12. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol. 1988;2:199-238.
13. Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007; 45(1):26-30.
14. Tamerius JD, Comrie AC. Coccidioidomycosis incidence in Arizona predicted by seasonal precipitation. PloS One. 2011;6(6):e21009.
15. Kolivras KN, Comrie AC. Modeling valley fever (coccidioidomycosis) incidence on the basis of climate conditions. Int J Biometeorol. 2003; 47(2):87-101.
16. Talamantes J, Behseta S, Zender CS. Fluctuations in climate and incidence of coccidioidomycosis in Kern County, California: a review. Ann N Y Acad Sci. 2007;1111:73-82.
17. Elconin AF, Egeberg RO, Egeberg MC. Significance of soil salinity on the ecology of coccidioides immitis. J Bacteriol. 1964;87:500-503.
18. Maddy KCH. Establishment of coccidioides immitis in negative soil following burial of infected animals and animal tissues. In: Ajello L, ed. Papers from the Second Symposium on Coccidioidomycosis. Tuscon, AZ: University of Arizona Press; 1967:309-312.
19. Egeberg RO, Ely AF. Coccidioides immitis in the soil of the southern San Joaquin Valley. Am J Med Sci. 1956;231(2):151-154.
20. Cordeiro Rde A, e Silva KR, Brilhante RS, et al. Coccidioides posadasii infection in bats, Brazil. Emerg Infect Dis. 2012;18(4):668-670.
21. Eulalio KD, de Macedo RL, Cavalcanti MA, Martins LM, Lazera MS, Wanke B. Coccidioides immitis isolated from armadillos (Dasypus novemcinctus) in the state of Piaui, northeast Brazil. Mycopathologia. 2001;149(2):57-61.
22. Sharpton TJ, Stajich JE, Rounsley SD, et al. Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives. Genome Res. 2009;19(10):1722-1731.
23. Shubitz LF. Comparative aspects of coccidioidomycosis in animals and humans. Ann N Y Acad Sci. 2007;1111:395-403.
24. Shubitz LE, Butkiewicz CD, Dial SM, Lindan CP. Incidence of coccidioides infection among dogs residing in a region in which the organism is endemic. J Am Vet Med Assoc. 2005;226(11): 1846-1850.
25. Gautam R, Srinath I, Clavijo A, et al. Identifying areas of high risk of human exposure to coccidioidomycosis in Texas using serology data from dogs. Zoonoses Public Health. 2013;60(2):174-181.
26. Edwards PQ, Palmer CE. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. Dis Chest. 1957;31(1):35-60.
27. Beadenkopf WG, Loosli CG, et al. Tuberculin, coccidioidin, and histoplasmin sensitivity in relation to pulmonary calcifications; a survey among 6,000 students at the University of Chicago. Public Health Rep. 1949;64(1):17-32.
28. Lauer A, Baal JD, Baal JC, Verma M, Chen JM. Detection of Coccidioides immitis in Kern County, California, by multiplex PCR. Mycologia. 2012;104(1):62-69.
29. Burt A, Dechairo BM, Koenig GL, Carter DA, White TJ, Taylor JW. Molecular markers reveal differentiation among isolates of Coccidioides immitis from California, Arizona and Texas. Mol Ecol. 1997;6(8): 781-786.
30. Centers for Disease Control and Prevention (CDC). Coccidioidomycosis-United States, 1991-1992. MMWR Morb Mortal Wkly Rep. 1993; 42(2):21-24.
31. Rios-Fabra A, Moreno AR, Isturiz RE. Fungal infection in Latin American countries. Infect Dis Clin North Am. 1994;8(1):129-154.
32. Rios-Olivares EO. 1st human case of coccidioidomycosis in Nicaragua. Rev Latinoam Microbiol. 1979;21(4):215-218.
33. Ajello L. Comparative ecology of respiratory mycotic disease agents. Bacteriol Rev. 1967;31(1):6-24.
34. Padua y Gabriel A, Martinez-Ordaz VA, Velasco-Rodreguez VM, Lazo-Saenz JG, Cicero R. Prevalence of skin reactivity to coccidioidin and associated risks factors in subjects living in a northern city of Mexico. Arch Med Res. 1999;30(5):388-392.
35. D'Avino A, Di Giambenedetto S, Fabbiani M, Farina S. Coccidioidomycosis of cervical lymph nodes in an HIV-infected patient with immunologic reconstitution on potent HAART: a rare observation in a nonendemic area. Diagn Microbiol Infect Dis. 2012;72(2): 185-187.
36. Kotton CN, Marconi VC, Fishman JA, Chung RT, Elias N, Hertl M. Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report. Transplantation. 2006;81(1):132-134.
37. Centers for Disease Control and Prevention (CDC). Coccidioidomycosis in Travelers Returning From Mexico-Pennsylvania, 2000. MMWR. 2000;49(44):1004-1006.
38. Cairns L, Blythe D, Kao A, et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis. 2000;30(1):61-64.
39. Standaert SM, Schaffner W, Galgiani JN, et al. Coccidioidomycosis among visitors to a Coccidioides immitis-endemic area: an outbreak in a military reserve unit. J Infect Dis. 1995;171(6):1672-1675.
40. Desai SA, Minai OA, Gordon SM, O'Neil B, Wiedemann HP, Arroliga AC. Coccidioidomycosis in non-endemic areas: a case series. Respir Med. 2001;95(4):305-309.
41. Chaturvedi V, Ramani R, Gromadzki S, Rodeghier B, Chang HG, Morse DL. Coccidioidomycosis in New York State. Emerg Infect Dis. 2000; 6(1):25-29.
42. Taxy JB, Kodros S. Musculoskeletal coccidioidomycosis: unusual sites of disease in a nonendemic area. Am J Clin Pathol. 2005;124(5): 693-696.
43. Desai NR, McGoey R, Troxclair D, Simeone F, Palomino J. Coccidioidomycosis in nonendemic area: case series and review of literature. J La State Med Soc. 2010;162(2):97-103.
44. Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis. 2002;35(9):1088-1095.
45. Centers for Disease Control and Prevention (CDC). Coccidioidomycosis among persons attending the world championship of model airplane flying-Kern County, California, Oct 2001. MMWR Morbidity and Mortality Weekly Report. 2001;50(49):1106-1107.
46. Clark TA HS, Johnson E, Mark K, et al. Coccidioidomycosis associated with the World Championship of Model Airplane Free Flight-Lost Hills, California, 2001. Proceedings of the Annual Coccidioidomycosis Study Group Meeting; 2002.
47. Marsden-Haug N, Goldoft M, Ralston C, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis. 2013;56(6):847-850.
48. Lan F, Tong YZ, Huang H, Xiong WN, Xu YJ, Xiong SD. Primary pulmonary coccidioidomycosis in China. Respirology. 2010;15(4): 722-725.
49. Dzawachiszwili N, Landau JW, Newcomer VD, Plunkett OA. The effect of sea water and sodium chloride on the growth of fungi pathogenic to man. J Invest Dermat. 1964;43:103-109.
50. Charlton V, Ramsdell K, Sehring S. Intrauterine transmission of coccidioidomycosis. Pediatr Infect Dis J. 1999;18(6):561-563.
51. Gaidici A, Saubolle MA. Transmission of coccidioidomycosis to a human via a cat bite. J Clin Microbiol. 2009;47(2):505-506.
52. Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med. 1972;286(10):507-512.
53. Cummings KC, McDowell A, Wheeler C, et al. Point-source outbreak of coccidioidomycosis in construction workers. Epidemiol Infect. 2010; 138(4):507-511.
54. Flynn NM, Hoeprich PD, Kawachi MM, et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med. 1979; 301(7):358-361.
55. Pappagianis D, Einstein H. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West J Med. 1978;129(6): 527-530.
56. Schneider E, Hajjeh RA, Spiegel RA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA. 1997; 277(11):904-908.
57. Wanke B, Lazera M, Monteiro PC, et al. Investigation of an outbreak of endemic coccidioidomycosis in Brazil's northeastern state of Piaui with a review of the occurrence and distribution of Coccidioides immitis in three other Brazilian states. Mycopathologia. 1999;148(2): 57-67.
58. Crum N, Lamb C, Utz G, Amundson D, Wallace M. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area-Coalinga, California. J Infect Dis. 2002;186(6): 865-868.
59. Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987;83(5):949-952.
60. Leake JA, Mosley DG, England B, et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis. 2000;181(4):1435-1440.
61. Sunenshine RH, Anderson S, Erhart L, et al. Public health surveillance for coccidioidomycosis in Arizona. Ann N Y Acad Sci. 2007;1111: 96-102.
62. Blair JE, Mayer AP, Currier J, Files JA, Wu Q. Coccidioidomycosis in elderly persons. Clin Infect Dis. 2008;47(12):1513-1518.
63. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis. 2001;32(5):708-715.
64. Hector RF, Rutherford GW, Tsang CA, et al. The public health impact of coccidioidomycosis in Arizona and California. Int J Environ Res Public Health. 2011;8(4):1150-1173.
65. Centers for Disease Control and Prevention (CDC). Increase in Coccidioidomycosis-California, 2000-2007. MMWR Morb Mortal Wkly Rep. 2009;58(5):105-109.
66. Drutz DJ, Huppert M, Sun SH, McGuire WL. Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infect Immun. 1981;32(2):897-907.
67. Smith CE, Beard RR, et al. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health Nations Health. 1946;36(12):1394-1402.
68. Durry E, Pappagianis D, Werner SB, et al. Coccidioidomycosis in Tulare County, California, 1991: reemergence of an endemic disease. J Med Vet Mycol. 1997;35(5):321-326.
69. Louie L, Ng S, Hajjeh R, et al. Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis. 1999;5(5):672-680.
70. Tabor JA, O'Rourke MK. A risk factor study of coccidioidomycosis by controlling differential misclassifications of exposure and susceptibility using a landscape ecology approach. Sci Total Environ. 2010; 408(10):2199-2207.
71. Tabor JA, O'Rourke MK, Lebowitz MD, Harris RB. Landscape-epidemiological study design to investigate an environmentally based disease. J Exp Sci Environ Epidemiol. 2011;21(2):197-211.
72. Deresinski SC, Pappagianis D, Stevens DA. Association of ABO blood group and outcome of coccidioidal infection. Sabouraudia. 1979; 17(3):261-264.
73. Vinh DC, Masannat F, Dzioba RB, Galgiani JN, Holland SM. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2009;49(6): e62-e65.
74. Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011;53(4): 363-368.
75. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006;119(11):993. e911-e997.
76. Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47,120 pregnancies. Chest. 1988;94(2):376-379.
77. Vaughan JE, Ramirez H. Coccidioidomycosis as a complication of pregnancy. Calif Med. 1951;74(2):121-125.
78. Smale LE, Waechter KG. Dissemination of coccidioidomycosis in pregnancy. Am J Obstet Gynecol. 1970;107(3):356-361.
79. Caldwell JW, Arsura EL, Kilgore WB, Garcia AL, Reddy V, Johnson RH. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet Gynecol. 2000;95(2):236-239.
80. Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis. 1984;6(6):814-831.
81. Blair JE, Smilack JD, Caples SM. Coccidioidomycosis in patients with hematologic malignancies. Arch Intern Med. 2005;165(1):113-117.
82. Mertz LE, Blair JE. Coccidioidomycosis in rheumatology patients: incidence and potential risk factors. Ann N Y Acad Sci. 2007;1111: 343-357.
83. Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119(11):964-969.
84. Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 2004;50(6):1959-1966.
85. Rutala PJ, Smith JW. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci. 1978;275(3):283-295.
86. Galgiani JN. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med. 1999; 130(4 Pt 1):293-300.
87. Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010;50(1):1-7.
88. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33(9):1536-1544.
89. Blair JE. Coccidioidomycosis in liver transplantation. Liver Transpl. 2006;12(1):31-39.
90. Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant. 2006;6(2): 340-345.
91. Vikram HR, Dosanjh A, Blair JE. Coccidioidomycosis and lung transplantation. Transplantation. 2011;92(7):717-721.
92. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982;142(3): 489-494.
93. Calhoun D, Galgiani J, Zukoski C. Coccidioidomycosis in recent renal or cardiac transplant recipients. Coccidioidomycosis: proceedings of the 4th International Conference on Coccidioidomycosis; 1984; San Diego.
94. Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci. 2007;1111:365-376.
95. Brugiere O, Forget E, Biondi G, et al. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation. 15, 2009;88(11):1319-1320.
96. Dierberg KL, Marr KA, Subramanian A, et al. Donor-derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis. 2012;14(3):300-304.
97. Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol. 2004;42(5):2347-2349.
98. Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg. 2002;73(1):306-308.
99. Blodget E, Geiseler PJ, Larsen RA, Stapfer M, Qazi Y, Petrovic LM. Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients. Transplant Infect Dis. 2012;14(3):305-310.
100. Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis. 2003;37(9):1265-1269.
101. Carvalho C, Ferreira I, Gaiao S, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transplant Infect Dis. 2010;12(2):151-154.
102. Blair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transplant Infect Dis. 2007;9(1):78-82.
103. Ampel NM. Coccidioidomycosis in persons infected with HIV-1. Ann N Y Acad Sci. 2007;1111:336-342.
104. Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis. 2000; 181(4):1428-1434.
105. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993;94(3):235-240.
106. Pappagianis D. Coccidioidomycosis in California state correctional institutions. Ann N Y Acad Sci. 2007;1111:103-111.
107. Coccidioidomycosis in California's Adult Prisons 2006-2010. California Correctional Health Care Services Public Health Unit and Quality Management; 2012.
108. Centers for Disease Control and Prevention (CDC). Coccidioidomycosis-Arizona, 1990-1995. MMWR Morb Mortal Wkly Rep. 1996;45(49):1069-1073.
109. Centers for Disease Control and Prevention (CDC). Increase in reported coccidioidomycosis-United States, 1998-2011. MMWR Morb Mortal Wkly Rep. 2013;62(12):217-221.
110. Tsang CA, Anderson SM, Imholte SB, et al. Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008. Emerg Infect Dis. 2010;16(11):1738-1744.
111. Kuberski T, Herrig J, Pappagianis D. False-positive IgM serology in coccidioidomycosis. J Clin Microbiol. 2010;48(6):2047-2049.
112. Blair JE, Mendoza N, Force S, Chang YH, Grys TE. Clinical specificity of the enzyme immunoassay test for coccidioidomycosis varies according to the reason for its performance. Clin Vaccine Immunol. 2013;20(1):95-98.
113. Pappagianis D. Serologic studies in coccidioidomycosis. Semin Respir Infect. 2001;16(4):242-250.
114. Durkin M, Connolly P, Kuberski T, et al. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis. 2008;47(8):e69-e73.
115. Kirsch EJ, Greene RT, Prahl A, et al. Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis. Clin Vaccine Immunol. 2012;19(3):343-345.
116. Benedict K, Park BJ. The re-emergence and changing epidemiology of coccidioidomycosis, United States, 1998-2010 (poster). Paper presented at: International Conference on Emerging Infectious Diseases; 2012; Atlanta, GA.
117. Ampel NM. What's behind the increasing rates of coccidioidomycosis in Arizona and California? Curr Infect Dis Rep. 2010;12(3):211-216.
118. Park BJ, Sigel K, Vaz V, et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis. 2005;191(11):1981-1987.
119. Centers for Disease Control and Prevention (CDC). Increase in coccidioidomycosis-Arizona 1998-2001. MMWR Morb Mortal Wkly Rep. 2003;52(6):109-112.
120. Fisher BT, Chiller TM, Prasad PA, Beveridge M, Walsh TJ, Zaoutis TE. Hospitalizations for coccidioidomycosis at forty-one children's hospitals in the United States. Pediatr Infect Dis J. 2010;29(3):243-247.
121. Flaherman VJ, Hector R, Rutherford GW. Estimating severe coccidioidomycosis in California. Emerg Infect Dis. 2007;13(7): 1087-1090.
122. Huang JY, Bristow B, Shafir S, Sorvillo F. Coccidioidomycosis-associated Deaths, United States, 1990-2008. Emerg Infect Dis. 2012; 18(11):1723-1728.
123. Ampel NM. Measurement of cellular immunity in human coccidioidomycosis. Mycopathologia. 2003;156(4):247-262.
124. Chen S, Erhart L, Anderson S, et al. Coccidioidomycosis: knowledge, attitudes, and practices among healthcare providers-Arizona, 2007. Med Mycol. 2011;49(6):649-656.
125. Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis. 2009;48(2):172-178.
126. Hector R, Rutherford GW. The public health need and present status of a vaccine for the prevention of coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:259-268.
127. Barnato AE, Sanders GD, Owens DK. Cost-effectiveness of a potential vaccine for Coccidioides immitis. Emerg Infect Dis. 2001;7(5): 797-806.